Vor Biopharma Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.60 | 0.00 | 0.00 | 0.00 | 1.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | 0.57 | 0.19 | 0.61 | 0.62 | 0.23 | 0.31 | 1.26 | 1.32 | 0.84 | 0.37 | 0.62 | 0.26 | 0.28 | 0.26 | 0.26 | 0.25 | 0.13 | 0.34 | – | 0.00 | 0.07 | – | – | |
| – | – | – | – | – | – | – | – | -0.57 | -0.19 | -0.61 | -0.62 | -0.23 | -0.31 | -1.26 | -1.32 | -0.84 | -0.37 | -0.62 | -0.26 | -0.28 | -0.26 | -0.26 | -0.25 | -0.13 | -0.34 | – | 0.00 | -0.07 | – | – | |
| 148.13 | 148.13 | 269.46 | 4.86 | 10.11 | 9.79 | 13.34 | 10.18 | 8.03 | 7.04 | 7.00 | 6.87 | 8.19 | 8.19 | 8.88 | 7.34 | 6.61 | 7.13 | 8.17 | 6.16 | 7.15 | 6.39 | 6.37 | 7.38 | 4.28 | 41.75 | 2.12 | 1.94 | 40.91 | 0.48 | 1.42 | |
| 98.13 | 98.13 | 369.14 | 1.58 | 2.80 | 3.38 | 5.97 | 3.89 | 4.30 | 2.94 | 3.07 | 3.04 | 4.03 | 3.45 | 3.80 | 3.30 | 2.57 | 2.47 | 2.28 | 2.13 | 2.35 | 2.11 | 1.96 | 1.74 | 1.06 | 0.38 | 2.16 | 1.70 | 40.77 | 0.40 | 1.30 | |
| 243.43 | 243.43 | 638.60 | 6.44 | 12.91 | 13.17 | 19.31 | 14.07 | 12.33 | 9.98 | 10.07 | 9.91 | 12.23 | 11.64 | 12.68 | 10.63 | 9.18 | 9.60 | 10.45 | 8.02 | 9.23 | 8.24 | 8.33 | 8.86 | 5.33 | 43.79 | 4.21 | 3.64 | 81.68 | 0.88 | 2.71 | |
| -246.27 | -246.27 | -638.60 | -6.44 | -12.91 | -13.17 | -19.31 | -14.07 | -12.33 | -9.98 | -10.07 | -9.91 | -12.23 | -11.64 | -12.68 | -10.63 | -9.18 | -9.60 | -10.45 | -8.29 | -9.50 | -8.50 | -8.33 | -9.11 | -5.33 | -43.79 | -4.21 | -3.64 | -81.75 | -0.88 | -2.71 | |
| – | – | – | 0.00 | – | – | – | 0.00 | – | – | – | – | 0.03 | 0.07 | 0.16 | 0.43 | 0.60 | – | – | 0.59 | – | – | – | – | – | – | – | – | – | – | – | |
| -293.69 | -293.69 | -625.37 | -6.38 | -12.86 | -13.17 | -19.31 | -14.07 | -12.33 | -9.97 | -10.05 | -9.88 | -12.19 | -11.57 | -12.52 | -10.28 | -8.58 | -8.94 | -9.82 | -7.74 | -9.06 | -8.15 | -8.05 | -8.94 | -5.21 | -251.24 | -121.63 | 174.52 | -510.53 | -1.16 | 11.56 | |
| 67.50 | 67.50 | 87.13 | 0.06 | – | – | – | 38.93 | -0.29 | – | -0.41 | 37.31 | -0.03 | -0.07 | -0.16 | -0.43 | -0.60 | 0.91 | 0.42 | 0.17 | 0.26 | 0.26 | – | -0.26 | – | – | – | – | – | – | – | |
| -361.19 | -361.19 | -712.49 | -6.38 | -12.86 | -13.17 | -19.31 | -14.07 | -12.33 | -9.97 | -10.05 | -9.88 | -12.19 | -11.57 | -12.52 | -10.28 | -8.58 | -8.94 | -9.82 | -7.74 | -9.06 | -8.15 | -8.05 | -8.94 | -5.21 | -251.24 | -121.63 | 174.52 | -510.53 | -1.16 | 11.56 | |
| -244.67 | -244.67 | -619.87 | -6.31 | -12.80 | -13.00 | -18.99 | -13.85 | -12.05 | -9.78 | -9.84 | -9.67 | -11.97 | -10.56 | -12.05 | -10.01 | -8.33 | -8.68 | -9.55 | -7.47 | -8.78 | -7.90 | -7.80 | -8.69 | -5.07 | -38.56 | -121.63 | 174.52 | -510.46 | -0.88 | 11.84 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.